TOLLIP Inhibits Psoriasis Progression via Suppressing PKM2‐Mediated Glycolysis in Keratinocytes
In this study, we identify TOLLIP as a critical regulator of psoriasis pathogenesis through its modulation of glycolytic metabolism. Our findings establish the TOLLIP‐PKM2‐glycolysis axis as a key mechanism linking metabolic reprogramming to psoriasis pathogenesis, and propose TOLLIP as a promising therapeutic target.
Xiuhuan Jiang +11 more
wiley +1 more source
Polyfunctional antibody signature defines protection in Andes hantavirus survival. [PDF]
Bravo F +18 more
europepmc +1 more source
Glycan pairing in therapeutic IgG orchestrates Fcγ receptor engagement and ADCC: an integrated structure-function approach for thorough evaluation of Fc N-glycans as critical quality attributes. [PDF]
Meudt M +9 more
europepmc +1 more source
Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. [PDF]
Fontana M +5 more
europepmc +1 more source
Sialic Acids in Kidney Disease: Immune Regulation, Complement Activation and Glomerular Injury. [PDF]
Spennacchio A +9 more
europepmc +1 more source
Anti-Aβ3-10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-κB pathway. [PDF]
You J, Liu Q, Li X.
europepmc +1 more source
Human CD21<sup>lo</sup>T-bet<sup>+</sup> B cells: Not as easy as "ABC"! [PDF]
Tangye SG.
europepmc +1 more source

